Home Infusion Therapy
Home infusion therapy providers delivering IV medications, nutritional support, and specialty drugs in home and clinic settings.
- 4
- Verticals
Overview
Home Infusion Therapy covers providers delivering IV medications, nutritional support, and specialty drugs in home and clinic settings. It is a growing, specialty-pharmacy-adjacent category led by scaled players (Option Care Health, CVS Coram) that combines pharmacy, nursing, and logistics.
Demand is driven by the shift of infusion from hospital to lower-cost home and ambulatory settings and by growth in specialty and biologic drugs. It is a consolidating, capability-intensive business at the intersection of home care and specialty pharmacy.
Market snapshot
No discrete Census NAICS code under home health — home infusion spans home health (621610) and pharmacy classifications, so the segment is not separately sized here.
Business model & economics
Revenue model
Drug margin plus nursing and infusion-service fees
Key economics
- Recurring revenue
- Moderate–High
- EBITDA margin
- Drug-margin- and mix-dependent
- Capex intensity
- Moderate
recurring chronic infusion
Characteristics
- Shift of infusion from hospital to home and ambulatory.
- Specialty and biologic drug growth.
- Combines pharmacy, nursing, and logistics.
M&A deal context
Who’s acquiring
- Home-infusion & specialty-pharmacy platforms
- Pharmacy strategics
- PE-backed consolidators
What’s driving deals
- Site-of-care shift to home infusion.
- Specialty-drug growth.
- Consolidation of capability-intensive providers.
Verticals in this segment
Find Home Infusion Therapy acquisition targets
Search Acquisera’s index for companies classified under Home Infusion Therapy (4.6.2) and build a targeted deal pipeline.
Search companies